Corporate Members
The Pennsylvania Society of Oncology and Hematology expresses its gratitude to our corporate members. Donations from the following companies help us in fulfilling our mission.
To learn more about becoming a Corporate Member, please click here.
To learn more about becoming a Corporate Member, please click here.
10k Members
AstraZeneca
About Us:
AstraZeneca focuses on innovative science and leadership in three main therapy areas: Oncology; Cardiovascular, Renal and Metabolism (CVRM); and Respiratory It has a broad R&D platform. It started with small molecules and biologic medicines and is now expanding our platforms with new technologies. With a patient focus, AstraZeneca has a balanced portfolio of specialty and primary care medicines. AstraZeneca Oncology pushes the boundaries of science to change the practice of medicine, transform the lives of patients living with cancer, and ultimately eliminate cancer as a cause of death.
Representative Contact:
Courtney Stanton: [email protected]
Social Media Links:
Website: https://www.astrazeneca.com/our-therapy-areas/oncology.html#!
Twitter: @AstraZenecaUS
Facebook: AstraZeneca US Community Connections
AstraZeneca focuses on innovative science and leadership in three main therapy areas: Oncology; Cardiovascular, Renal and Metabolism (CVRM); and Respiratory It has a broad R&D platform. It started with small molecules and biologic medicines and is now expanding our platforms with new technologies. With a patient focus, AstraZeneca has a balanced portfolio of specialty and primary care medicines. AstraZeneca Oncology pushes the boundaries of science to change the practice of medicine, transform the lives of patients living with cancer, and ultimately eliminate cancer as a cause of death.
Representative Contact:
Courtney Stanton: [email protected]
Social Media Links:
Website: https://www.astrazeneca.com/our-therapy-areas/oncology.html#!
Twitter: @AstraZenecaUS
Facebook: AstraZeneca US Community Connections
Bristol Myers
About us:
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
Website:
https://www.bms.com/
BMS Access Support patient assistance: https://www.bmsaccesssupport.bmscustomerconnect.com/#
Representative:
Rich Boyle
Associate Director – US State Societies and Congresses
US Hematology & Cell Therapy Portfolio Marketing and Channel Strategy
Mobile (570) 241-2441
[email protected]
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
Website:
https://www.bms.com/
BMS Access Support patient assistance: https://www.bmsaccesssupport.bmscustomerconnect.com/#
Representative:
Rich Boyle
Associate Director – US State Societies and Congresses
US Hematology & Cell Therapy Portfolio Marketing and Channel Strategy
Mobile (570) 241-2441
[email protected]
Daiichi-Sankyo
About us:
The mission of Daiichi Sankyo Cancer Enterprise is to leverage our world-class, innovative science and push beyond traditional thinking to create meaningful treatments for patients with cancer. We are dedicated to transforming science into value for patients, and this sense of obligation informs everything we do. Anchored by our DXd antibody drug conjugate (ADC) technology, our powerful research engines include biologics, medicinal chemistry, modality and other research laboratories in Japan, and Plexxikon Inc., our small molecule structure-guided R&D center in Berkeley, CA. For more information, please visit: www.DSCancerEnterprise.com.
Website:
www.DSCancerEnterprise.com ; www.dsi.com
Representative Contact:
Darren Geissler, [email protected], 717-903-8948
Social Media:
Twitter: https://twitter.com/DaiichiSankyoUS
LinkedIn: https://www.linkedin.com/company/daiichi-sankyo/
The mission of Daiichi Sankyo Cancer Enterprise is to leverage our world-class, innovative science and push beyond traditional thinking to create meaningful treatments for patients with cancer. We are dedicated to transforming science into value for patients, and this sense of obligation informs everything we do. Anchored by our DXd antibody drug conjugate (ADC) technology, our powerful research engines include biologics, medicinal chemistry, modality and other research laboratories in Japan, and Plexxikon Inc., our small molecule structure-guided R&D center in Berkeley, CA. For more information, please visit: www.DSCancerEnterprise.com.
Website:
www.DSCancerEnterprise.com ; www.dsi.com
Representative Contact:
Darren Geissler, [email protected], 717-903-8948
Social Media:
Twitter: https://twitter.com/DaiichiSankyoUS
LinkedIn: https://www.linkedin.com/company/daiichi-sankyo/
Gilead
About Us:
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved milestones in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to developing and advancing innovative medicines to prevent and treat life-threatening diseases. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com. © 2022 Gilead Sciences, Inc. All rights reserved. -
Website: www.gilead.com
Representative Contacts: Nicole Cornett – Regional Business Director – [email protected] - 201 341-4605
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved milestones in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to developing and advancing innovative medicines to prevent and treat life-threatening diseases. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com. © 2022 Gilead Sciences, Inc. All rights reserved. -
Website: www.gilead.com
Representative Contacts: Nicole Cornett – Regional Business Director – [email protected] - 201 341-4605
Jazz Pharma
About Us
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases—often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology. We are a leader in sleep disorders and epilepsy; further developing in movement disorders and PTSD; and focused on hematologic malignancies and solid tumors. Within these therapeutic areas, we are identifying new options for patients by actively exploring small molecules, biologics, innovative delivery technologies and cannabinoid science. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in nearly 75 countries. Please visit www.jazzpharmaceuticals.com for more information.
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases—often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology. We are a leader in sleep disorders and epilepsy; further developing in movement disorders and PTSD; and focused on hematologic malignancies and solid tumors. Within these therapeutic areas, we are identifying new options for patients by actively exploring small molecules, biologics, innovative delivery technologies and cannabinoid science. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in nearly 75 countries. Please visit www.jazzpharmaceuticals.com for more information.
Janssen
About Us:
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.
Website: Learn more at https://www.jnj.com/ or at www.janssen.com/johnson-johnson-innovative-medicine.
Social Media: Follow us at @JanssenUS and @JNJInnovMed
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.
Website: Learn more at https://www.jnj.com/ or at www.janssen.com/johnson-johnson-innovative-medicine.
Social Media: Follow us at @JanssenUS and @JNJInnovMed
Merck
Social Media:
LinkedIn: linkedin.com/company/Merck
Facebook: www.facebook.com/Merckinvents
Twitter: twitter.com/Merck
Instagram: instagram.com/Merck
YouTube: youtube.com/user/Merck
LinkedIn: linkedin.com/company/Merck
Facebook: www.facebook.com/Merckinvents
Twitter: twitter.com/Merck
Instagram: instagram.com/Merck
YouTube: youtube.com/user/Merck
Pfizer
Company Website
htps://www.pfizer.com
Company Description:
At Pfizer Oncology, we are at the forefront of a new era in cancer care. Our industry-leading portfolio and extensive pipeline includes game-changing mechanisms of action to attack cancer from multiple angles, including antibody-drug conjugates (ADCs), small molecules, bispecifics and other immunotherapies. We are focused on delivering transformative therapies in some of the world’s most common cancers, including breast cancer, genitourinary cancer and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological and thoracic cancers, which includes lung cancer. Driven by science, we are committed to accelerating breakthroughs to extend and improve patients’ lives.
Social Media Links
Twitter/X: https://www.x.com/PfizerOncMed
LinkedIn: https://www.linkedin.com/company/Pfizer
Facebook: https://www.facebook.com/Pfizer
Instagram: https://www.instagram.com/PfizerInc
Address
66 Hudson Blvd. East
New York, NY 10001-2192
htps://www.pfizer.com
Company Description:
At Pfizer Oncology, we are at the forefront of a new era in cancer care. Our industry-leading portfolio and extensive pipeline includes game-changing mechanisms of action to attack cancer from multiple angles, including antibody-drug conjugates (ADCs), small molecules, bispecifics and other immunotherapies. We are focused on delivering transformative therapies in some of the world’s most common cancers, including breast cancer, genitourinary cancer and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological and thoracic cancers, which includes lung cancer. Driven by science, we are committed to accelerating breakthroughs to extend and improve patients’ lives.
Social Media Links
Twitter/X: https://www.x.com/PfizerOncMed
LinkedIn: https://www.linkedin.com/company/Pfizer
Facebook: https://www.facebook.com/Pfizer
Instagram: https://www.instagram.com/PfizerInc
Address
66 Hudson Blvd. East
New York, NY 10001-2192
Regeneron
About Us:
Regeneron is a leading science-based biopharmaceutical company that invents, develops and commercializes medicines to treat serious medical conditions.
Website: www.regeneron.com
Representative Contacts:
Paul Scharf - Key Account Leader [email protected]
Melissa Taylor – Reimbursement Business Manager [email protected]
Selena Kent - Senior Oncology Account Specialist – [email protected]
John Honus – Oncology Account Specialist - [email protected]
Josette Gephart – Oncology Account Specialist – [email protected]
Jacqueline Matthews – Oncology Account Specialist – [email protected]
Brandy Kurrell – Oncology Account Specialist - [email protected]
Reimbursement Link: https://www.libtayohcp.com/libtayo-surround
Social Media Links:
Facebook: https://www.facebook.com/Regeneron/
Twitter: https://twitter.com/Regeneron?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor
LinkedIn: https://www.linkedin.com/company/regeneron-pharmaceuticals
Instagram: https://www.instagram.com/regeneron/?hl=en
Regeneron is a leading science-based biopharmaceutical company that invents, develops and commercializes medicines to treat serious medical conditions.
Website: www.regeneron.com
Representative Contacts:
Paul Scharf - Key Account Leader [email protected]
Melissa Taylor – Reimbursement Business Manager [email protected]
Selena Kent - Senior Oncology Account Specialist – [email protected]
John Honus – Oncology Account Specialist - [email protected]
Josette Gephart – Oncology Account Specialist – [email protected]
Jacqueline Matthews – Oncology Account Specialist – [email protected]
Brandy Kurrell – Oncology Account Specialist - [email protected]
Reimbursement Link: https://www.libtayohcp.com/libtayo-surround
Social Media Links:
Facebook: https://www.facebook.com/Regeneron/
Twitter: https://twitter.com/Regeneron?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor
LinkedIn: https://www.linkedin.com/company/regeneron-pharmaceuticals
Instagram: https://www.instagram.com/regeneron/?hl=en
5k Members
Amgen
About Us:
At Amgen Oncology, our mission to serve patients drives all that we do. That's why we're relentlessly focused on accelerating the delivery of medicines that have the potential to empower all angles of care and transform lives of people with cancer. For the last four decades, we have been dedicated to discovering the firsts that matter in oncology and to finding ways to reduce the burden of cancer. Building on our heritage, Amgen continues to advance the largest pipeline in the Company's history, moving with great speed to advance those innovations for the patients who need them.
Website:
www.amgenoncology.com/
Representatives:
Nick Arena
Cell: 609.502.1200;
[email protected]
Social Media:
Twitter: twitter.com/amgenoncology
At Amgen Oncology, our mission to serve patients drives all that we do. That's why we're relentlessly focused on accelerating the delivery of medicines that have the potential to empower all angles of care and transform lives of people with cancer. For the last four decades, we have been dedicated to discovering the firsts that matter in oncology and to finding ways to reduce the burden of cancer. Building on our heritage, Amgen continues to advance the largest pipeline in the Company's history, moving with great speed to advance those innovations for the patients who need them.
Website:
www.amgenoncology.com/
Representatives:
Nick Arena
Cell: 609.502.1200;
[email protected]
Social Media:
Twitter: twitter.com/amgenoncology
Aveo
About Us:
AVEO Oncology (“AVEO”) is an oncology-focused biopharmaceutical company committed to providing innovative solutions to improve cancer patients’ lives. On January 20, 2023, AVEO was acquired by LG Chem, Ltd. (“LG Chem”), establishing a U.S. commercial presence for LG Chem and expanding LG Chem’s global oncology portfolio. AVEO continues to commercialize FOTIVDA® (tivozanib) in the U.S. To learn more about FOTIVDA efficacy, safety, and relevant resources, visit FOTIVDAHCP.com.
Website:
https://www.aveooncology.com
Representative:
Jenny Passett – Oncology Account Manager
(716) 713-6708
[email protected]
Aveo Oncology – 30 Winter Street, Boston, MA 02108
Social Media:
Twitter: https://twitter.com/aveooncology
LinkedIn: https://www.linkedin.com/company/54167?trk=tyah
AVEO Oncology (“AVEO”) is an oncology-focused biopharmaceutical company committed to providing innovative solutions to improve cancer patients’ lives. On January 20, 2023, AVEO was acquired by LG Chem, Ltd. (“LG Chem”), establishing a U.S. commercial presence for LG Chem and expanding LG Chem’s global oncology portfolio. AVEO continues to commercialize FOTIVDA® (tivozanib) in the U.S. To learn more about FOTIVDA efficacy, safety, and relevant resources, visit FOTIVDAHCP.com.
Website:
https://www.aveooncology.com
Representative:
Jenny Passett – Oncology Account Manager
(716) 713-6708
[email protected]
Aveo Oncology – 30 Winter Street, Boston, MA 02108
Social Media:
Twitter: https://twitter.com/aveooncology
LinkedIn: https://www.linkedin.com/company/54167?trk=tyah
Eli Lilly and Company
About Lilly
Lilly unites caring with discovery to create medicines that make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer's disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/newsroom or follow us on Facebook, Instagram, Twitter and LinkedIn.
For questions on the corporate boilerplate, please contact [email protected].
Website:
www.lilly.com
Representatives:
Kevin Coyne
Sr.Executive Account Manager, Regional Oncology
Lilly Value and Access
570-406-1548 (mobile)
[email protected]
Jennifer Mercado
Executive Business Director, Philadelphia Oncology District
609.667.8828 (office) | 609.975.2468 (mobile)
[email protected]
Social Media:
follow us on Facebook, Instagram, Twitter and LinkedIn
Lilly unites caring with discovery to create medicines that make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer's disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/newsroom or follow us on Facebook, Instagram, Twitter and LinkedIn.
For questions on the corporate boilerplate, please contact [email protected].
Website:
www.lilly.com
Representatives:
Kevin Coyne
Sr.Executive Account Manager, Regional Oncology
Lilly Value and Access
570-406-1548 (mobile)
[email protected]
Jennifer Mercado
Executive Business Director, Philadelphia Oncology District
609.667.8828 (office) | 609.975.2468 (mobile)
[email protected]
Social Media:
follow us on Facebook, Instagram, Twitter and LinkedIn
EMD Serono
Website:
https://www.emdserono.com/us-en/expertise/oncology.html
Contacts:
[email protected]
[email protected]
[email protected]
Patient Assistance Programs:
Bavencio - Home (coverone.com)
Tepmetko - Home (oncnavigationcenter.com)
https://www.emdserono.com/us-en/expertise/oncology.html
Contacts:
[email protected]
[email protected]
[email protected]
Patient Assistance Programs:
Bavencio - Home (coverone.com)
Tepmetko - Home (oncnavigationcenter.com)
Kyowa Kirin
About us:
Kyowa Kirin strives to create and deliver novel medicines with life-changing value. As a Japan-based Global Specialty Pharmaceutical Company, we apply cutting-edge science and expertise in antibody research and engineering to address the needs of patients and society across multiple therapeutic areas, including Nephrology, Oncology, Immunology/Allergy and Neurology. Across four global regions – Japan, Asia Pacific, North America and EMEA/International – we are united by our shared values of commitment to life, teamwork/Wa, innovation, and integrity, and a drive to advance innovations that have a profound impact on patients. You can learn more about Kyowa Kirin North America at: https://kkna.kyowakirin.com.
Website:
https://kkna.kyowakirin.com
Representative:
Nicole Lesterick, Oncology Account Manager, Kyowa Kirin, Inc., 135 US-202, Bedminster, NJ 07921
Social Media
LinkedIn: Kyowa Kirin, Inc.- U.S.
Twitter: @KyowaKirin_US
YouTube: Kyowa Kirin North America
Kyowa Kirin strives to create and deliver novel medicines with life-changing value. As a Japan-based Global Specialty Pharmaceutical Company, we apply cutting-edge science and expertise in antibody research and engineering to address the needs of patients and society across multiple therapeutic areas, including Nephrology, Oncology, Immunology/Allergy and Neurology. Across four global regions – Japan, Asia Pacific, North America and EMEA/International – we are united by our shared values of commitment to life, teamwork/Wa, innovation, and integrity, and a drive to advance innovations that have a profound impact on patients. You can learn more about Kyowa Kirin North America at: https://kkna.kyowakirin.com.
Website:
https://kkna.kyowakirin.com
Representative:
Nicole Lesterick, Oncology Account Manager, Kyowa Kirin, Inc., 135 US-202, Bedminster, NJ 07921
Social Media
LinkedIn: Kyowa Kirin, Inc.- U.S.
Twitter: @KyowaKirin_US
YouTube: Kyowa Kirin North America
Pfizer Oncology
Representatives:
Sue Sproat, CPC, CHONC, CMR, Field Reimbursement Manager - MD, DC, DE, PA
410-627-0807 (cell) | 484-323-7995 (fax)
[email protected]
Sue Sproat, CPC, CHONC, CMR, Field Reimbursement Manager - MD, DC, DE, PA
410-627-0807 (cell) | 484-323-7995 (fax)
[email protected]
Sanofi
Website:
www.sanofioncology.com
Representatives:
Nanette Rutherford, Field Reimbursement Manager
724-708-6495
[email protected]
Social Media:
Facebook: https://www.facebook.com/Sanofi/
LinkedIn: https://www.linkedin.com/company/sanofi
Twitter: https://twitter.com/SanofiUS
Instagram: https://www.instagram.com/sanofi/
CareASSIST Patient Support Information:
www.sanofioncology.com
Representatives:
Nanette Rutherford, Field Reimbursement Manager
724-708-6495
[email protected]
Social Media:
Facebook: https://www.facebook.com/Sanofi/
LinkedIn: https://www.linkedin.com/company/sanofi
Twitter: https://twitter.com/SanofiUS
Instagram: https://www.instagram.com/sanofi/
CareASSIST Patient Support Information:
